About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Renal Cancer Drug Market Size, Share And Growth Report, 2031
Renal Cancer Drug Market

Renal Cancer Drug Market Size, Share & Trends Analysis Report By Type (Clear Cell, Papillary, Chromophobe, Oncocytic, Collecting Duct, Others), By Therapeutic Class (Targeted Therapy, Immuno Therapy), By Pharmacologic Class (Angiogenesis Inhibitors, mTOR Inhibitors, Monoclonal Antibodies, Cytokine Immunotherapy (IL-2)), By End-Users (Hospitals and clinics, Ambulatory surgical centers, Diagnostic centers, Research centers, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH55486DR
Last Updated : Dec 11, 2023
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Renal Cancer Drug Market, By Type (2021-2031)
    1. Clear Cell
    2. Papillary
    3. Chromophobe
    4. Oncocytic
    5. Collecting Duct
    6. Others
  2. Renal Cancer Drug Market, By Therapeutic Class (2021-2031)
    1. Targeted Therapy
    2. Immuno Therapy
  3. Renal Cancer Drug Market, By Pharmacologic Class (2021-2031)
    1. Angiogenesis Inhibitors
    2. mTOR Inhibitors
    3. Monoclonal Antibodies
    4. Cytokine Immunotherapy (IL-2)
  4. Renal Cancer Drug Market, By End-Users (2021-2031)
    1. Hospitals and clinics
    2. Ambulatory surgical centers
    3. Diagnostic centers
    4. Research centers
    5. Others
    1. North America
      1. North America Renal Cancer Drug Market, By Type
        1. Clear Cell
          1. Papillary
            1. Chromophobe
              1. Oncocytic
                1. Collecting Duct
                  1. Others
                  2. North America Renal Cancer Drug Market, By Therapeutic Class
                    1. Targeted Therapy
                      1. Immuno Therapy
                      2. North America Renal Cancer Drug Market, By Pharmacologic Class
                        1. Angiogenesis Inhibitors
                          1. mTOR Inhibitors
                            1. Monoclonal Antibodies
                              1. Cytokine Immunotherapy (IL-2)
                              2. North America Renal Cancer Drug Market, By End-Users
                                1. Hospitals and clinics
                                  1. Ambulatory surgical centers
                                    1. Diagnostic centers
                                      1. Research centers
                                        1. Others
                                        2. U.S.
                                          1. U.S. Renal Cancer Drug Market, By Type
                                            1. Clear Cell
                                              1. Papillary
                                                1. Chromophobe
                                                  1. Oncocytic
                                                    1. Collecting Duct
                                                      1. Others
                                                      2. U.S. Renal Cancer Drug Market, By Therapeutic Class
                                                        1. Targeted Therapy
                                                          1. Immuno Therapy
                                                          2. U.S. Renal Cancer Drug Market, By Pharmacologic Class
                                                            1. Angiogenesis Inhibitors
                                                              1. mTOR Inhibitors
                                                                1. Monoclonal Antibodies
                                                                  1. Cytokine Immunotherapy (IL-2)
                                                                  2. U.S. Renal Cancer Drug Market, By End-Users
                                                                    1. Hospitals and clinics
                                                                      1. Ambulatory surgical centers
                                                                        1. Diagnostic centers
                                                                          1. Research centers
                                                                            1. Others
                                                                          2. Canada
                                                                        2. Europe
                                                                          1. Europe Renal Cancer Drug Market, By Type
                                                                            1. Clear Cell
                                                                              1. Papillary
                                                                                1. Chromophobe
                                                                                  1. Oncocytic
                                                                                    1. Collecting Duct
                                                                                      1. Others
                                                                                      2. Europe Renal Cancer Drug Market, By Therapeutic Class
                                                                                        1. Targeted Therapy
                                                                                          1. Immuno Therapy
                                                                                          2. Europe Renal Cancer Drug Market, By Pharmacologic Class
                                                                                            1. Angiogenesis Inhibitors
                                                                                              1. mTOR Inhibitors
                                                                                                1. Monoclonal Antibodies
                                                                                                  1. Cytokine Immunotherapy (IL-2)
                                                                                                  2. Europe Renal Cancer Drug Market, By End-Users
                                                                                                    1. Hospitals and clinics
                                                                                                      1. Ambulatory surgical centers
                                                                                                        1. Diagnostic centers
                                                                                                          1. Research centers
                                                                                                            1. Others
                                                                                                            2. U.K.
                                                                                                              1. U.K. Renal Cancer Drug Market, By Type
                                                                                                                1. Clear Cell
                                                                                                                  1. Papillary
                                                                                                                    1. Chromophobe
                                                                                                                      1. Oncocytic
                                                                                                                        1. Collecting Duct
                                                                                                                          1. Others
                                                                                                                          2. U.K. Renal Cancer Drug Market, By Therapeutic Class
                                                                                                                            1. Targeted Therapy
                                                                                                                              1. Immuno Therapy
                                                                                                                              2. U.K. Renal Cancer Drug Market, By Pharmacologic Class
                                                                                                                                1. Angiogenesis Inhibitors
                                                                                                                                  1. mTOR Inhibitors
                                                                                                                                    1. Monoclonal Antibodies
                                                                                                                                      1. Cytokine Immunotherapy (IL-2)
                                                                                                                                      2. U.K. Renal Cancer Drug Market, By End-Users
                                                                                                                                        1. Hospitals and clinics
                                                                                                                                          1. Ambulatory surgical centers
                                                                                                                                            1. Diagnostic centers
                                                                                                                                              1. Research centers
                                                                                                                                                1. Others
                                                                                                                                              2. Germany
                                                                                                                                              3. France
                                                                                                                                              4. Spain
                                                                                                                                              5. Italy
                                                                                                                                              6. Russia
                                                                                                                                              7. Nordic
                                                                                                                                              8. Benelux
                                                                                                                                              9. Rest of Europe
                                                                                                                                            2. APAC
                                                                                                                                              1. APAC Renal Cancer Drug Market, By Type
                                                                                                                                                1. Clear Cell
                                                                                                                                                  1. Papillary
                                                                                                                                                    1. Chromophobe
                                                                                                                                                      1. Oncocytic
                                                                                                                                                        1. Collecting Duct
                                                                                                                                                          1. Others
                                                                                                                                                          2. APAC Renal Cancer Drug Market, By Therapeutic Class
                                                                                                                                                            1. Targeted Therapy
                                                                                                                                                              1. Immuno Therapy
                                                                                                                                                              2. APAC Renal Cancer Drug Market, By Pharmacologic Class
                                                                                                                                                                1. Angiogenesis Inhibitors
                                                                                                                                                                  1. mTOR Inhibitors
                                                                                                                                                                    1. Monoclonal Antibodies
                                                                                                                                                                      1. Cytokine Immunotherapy (IL-2)
                                                                                                                                                                      2. APAC Renal Cancer Drug Market, By End-Users
                                                                                                                                                                        1. Hospitals and clinics
                                                                                                                                                                          1. Ambulatory surgical centers
                                                                                                                                                                            1. Diagnostic centers
                                                                                                                                                                              1. Research centers
                                                                                                                                                                                1. Others
                                                                                                                                                                                2. China
                                                                                                                                                                                  1. China Renal Cancer Drug Market, By Type
                                                                                                                                                                                    1. Clear Cell
                                                                                                                                                                                      1. Papillary
                                                                                                                                                                                        1. Chromophobe
                                                                                                                                                                                          1. Oncocytic
                                                                                                                                                                                            1. Collecting Duct
                                                                                                                                                                                              1. Others
                                                                                                                                                                                              2. China Renal Cancer Drug Market, By Therapeutic Class
                                                                                                                                                                                                1. Targeted Therapy
                                                                                                                                                                                                  1. Immuno Therapy
                                                                                                                                                                                                  2. China Renal Cancer Drug Market, By Pharmacologic Class
                                                                                                                                                                                                    1. Angiogenesis Inhibitors
                                                                                                                                                                                                      1. mTOR Inhibitors
                                                                                                                                                                                                        1. Monoclonal Antibodies
                                                                                                                                                                                                          1. Cytokine Immunotherapy (IL-2)
                                                                                                                                                                                                          2. China Renal Cancer Drug Market, By End-Users
                                                                                                                                                                                                            1. Hospitals and clinics
                                                                                                                                                                                                              1. Ambulatory surgical centers
                                                                                                                                                                                                                1. Diagnostic centers
                                                                                                                                                                                                                  1. Research centers
                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                  2. Korea
                                                                                                                                                                                                                  3. Japan
                                                                                                                                                                                                                  4. India
                                                                                                                                                                                                                  5. Australia
                                                                                                                                                                                                                  6. Singapore
                                                                                                                                                                                                                  7. Taiwan
                                                                                                                                                                                                                  8. South East Asia
                                                                                                                                                                                                                  9. Rest of Asia-Pacific
                                                                                                                                                                                                                2. Middle East and Africa
                                                                                                                                                                                                                  1. Middle East and Africa Renal Cancer Drug Market, By Type
                                                                                                                                                                                                                    1. Clear Cell
                                                                                                                                                                                                                      1. Papillary
                                                                                                                                                                                                                        1. Chromophobe
                                                                                                                                                                                                                          1. Oncocytic
                                                                                                                                                                                                                            1. Collecting Duct
                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                              2. Middle East and Africa Renal Cancer Drug Market, By Therapeutic Class
                                                                                                                                                                                                                                1. Targeted Therapy
                                                                                                                                                                                                                                  1. Immuno Therapy
                                                                                                                                                                                                                                  2. Middle East and Africa Renal Cancer Drug Market, By Pharmacologic Class
                                                                                                                                                                                                                                    1. Angiogenesis Inhibitors
                                                                                                                                                                                                                                      1. mTOR Inhibitors
                                                                                                                                                                                                                                        1. Monoclonal Antibodies
                                                                                                                                                                                                                                          1. Cytokine Immunotherapy (IL-2)
                                                                                                                                                                                                                                          2. Middle East and Africa Renal Cancer Drug Market, By End-Users
                                                                                                                                                                                                                                            1. Hospitals and clinics
                                                                                                                                                                                                                                              1. Ambulatory surgical centers
                                                                                                                                                                                                                                                1. Diagnostic centers
                                                                                                                                                                                                                                                  1. Research centers
                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                    2. UAE
                                                                                                                                                                                                                                                      1. UAE Renal Cancer Drug Market, By Type
                                                                                                                                                                                                                                                        1. Clear Cell
                                                                                                                                                                                                                                                          1. Papillary
                                                                                                                                                                                                                                                            1. Chromophobe
                                                                                                                                                                                                                                                              1. Oncocytic
                                                                                                                                                                                                                                                                1. Collecting Duct
                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                  2. UAE Renal Cancer Drug Market, By Therapeutic Class
                                                                                                                                                                                                                                                                    1. Targeted Therapy
                                                                                                                                                                                                                                                                      1. Immuno Therapy
                                                                                                                                                                                                                                                                      2. UAE Renal Cancer Drug Market, By Pharmacologic Class
                                                                                                                                                                                                                                                                        1. Angiogenesis Inhibitors
                                                                                                                                                                                                                                                                          1. mTOR Inhibitors
                                                                                                                                                                                                                                                                            1. Monoclonal Antibodies
                                                                                                                                                                                                                                                                              1. Cytokine Immunotherapy (IL-2)
                                                                                                                                                                                                                                                                              2. UAE Renal Cancer Drug Market, By End-Users
                                                                                                                                                                                                                                                                                1. Hospitals and clinics
                                                                                                                                                                                                                                                                                  1. Ambulatory surgical centers
                                                                                                                                                                                                                                                                                    1. Diagnostic centers
                                                                                                                                                                                                                                                                                      1. Research centers
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                      1. LATAM Renal Cancer Drug Market, By Type
                                                                                                                                                                                                                                                                                        1. Clear Cell
                                                                                                                                                                                                                                                                                          1. Papillary
                                                                                                                                                                                                                                                                                            1. Chromophobe
                                                                                                                                                                                                                                                                                              1. Oncocytic
                                                                                                                                                                                                                                                                                                1. Collecting Duct
                                                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                                                  2. LATAM Renal Cancer Drug Market, By Therapeutic Class
                                                                                                                                                                                                                                                                                                    1. Targeted Therapy
                                                                                                                                                                                                                                                                                                      1. Immuno Therapy
                                                                                                                                                                                                                                                                                                      2. LATAM Renal Cancer Drug Market, By Pharmacologic Class
                                                                                                                                                                                                                                                                                                        1. Angiogenesis Inhibitors
                                                                                                                                                                                                                                                                                                          1. mTOR Inhibitors
                                                                                                                                                                                                                                                                                                            1. Monoclonal Antibodies
                                                                                                                                                                                                                                                                                                              1. Cytokine Immunotherapy (IL-2)
                                                                                                                                                                                                                                                                                                              2. LATAM Renal Cancer Drug Market, By End-Users
                                                                                                                                                                                                                                                                                                                1. Hospitals and clinics
                                                                                                                                                                                                                                                                                                                  1. Ambulatory surgical centers
                                                                                                                                                                                                                                                                                                                    1. Diagnostic centers
                                                                                                                                                                                                                                                                                                                      1. Research centers
                                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                                        2. Brazil
                                                                                                                                                                                                                                                                                                                          1. Brazil Renal Cancer Drug Market, By Type
                                                                                                                                                                                                                                                                                                                            1. Clear Cell
                                                                                                                                                                                                                                                                                                                              1. Papillary
                                                                                                                                                                                                                                                                                                                                1. Chromophobe
                                                                                                                                                                                                                                                                                                                                  1. Oncocytic
                                                                                                                                                                                                                                                                                                                                    1. Collecting Duct
                                                                                                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                                                                                                      2. Brazil Renal Cancer Drug Market, By Therapeutic Class
                                                                                                                                                                                                                                                                                                                                        1. Targeted Therapy
                                                                                                                                                                                                                                                                                                                                          1. Immuno Therapy
                                                                                                                                                                                                                                                                                                                                          2. Brazil Renal Cancer Drug Market, By Pharmacologic Class
                                                                                                                                                                                                                                                                                                                                            1. Angiogenesis Inhibitors
                                                                                                                                                                                                                                                                                                                                              1. mTOR Inhibitors
                                                                                                                                                                                                                                                                                                                                                1. Monoclonal Antibodies
                                                                                                                                                                                                                                                                                                                                                  1. Cytokine Immunotherapy (IL-2)
                                                                                                                                                                                                                                                                                                                                                  2. Brazil Renal Cancer Drug Market, By End-Users
                                                                                                                                                                                                                                                                                                                                                    1. Hospitals and clinics
                                                                                                                                                                                                                                                                                                                                                      1. Ambulatory surgical centers
                                                                                                                                                                                                                                                                                                                                                        1. Diagnostic centers
                                                                                                                                                                                                                                                                                                                                                          1. Research centers
                                                                                                                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                                                                                                                                                                                          4. Chile
                                                                                                                                                                                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                                      Related Reports

                                                                                                                                                                                                                                                                                                                                                      Global Report
                                                                                                                                                                                                                                                                                                                                                      The global oncology cancer drugs market size was valued at USD 148.05 billion in 2021. It is expected to reach USD 288.63 billion by 2030, growing at a CAGR of 7.7% during the forecast period (2022–2030). Cancer is characterized by th
                                                                                                                                                                                                                                                                                                                                                      Buy Now

                                                                                                                                                                                                                                                                                                                                                      Purchase Benefits

                                                                                                                                                                                                                                                                                                                                                      • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                                      • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                                      • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                                      • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                                      • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                                      • Permission to print the report

                                                                                                                                                                                                                                                                                                                                                      We are featured on :

                                                                                                                                                                                                                                                                                                                                                      www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                                      © Copyright . All rights Reserved.